FCGR3B and COVID-19: COVID-19 was reported to share two CD14+CD16+ inflammatory macrophage phenotypes with these diseases: one characterized by a CXCL10+CCL2+ cytokine signature, as well as a population expressing the pathogen recognition and complement lectin pathway receptor FCN1/Ficolin-1 (34).